Found 754 matching trials
Randomized Clinical Study Assessing Haplo vs. URD in AML NA This study compares haplo-identical family donor stem cell transplantation ...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients PHASE2 This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Show More Location
Tower Cancer Research Foundation
Learn More & Join Trial
AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis PHASE1 One of the possible options for the treatment of MS at present is a high-do...
Show More Location
First Pavlov State Medical University of St. Petersburg
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression PHASE2 Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Show More Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer PHASE2 This multi-center, open-label, phase II randomized controlled trial is to e...
Show More Location
Sun Yat-sen Memorial Hospital
Learn More & Join Trial
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole PHASE2 SIR-POSA is a phase II trial of peripheral blood stem cell (PBSC) transplan...
Show More Location
Ospedale San Raffaele
Learn More & Join Trial
Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma PHASE2 Objectives:
A. Primary objective:
1 To assess the feasibility and the eff...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer PHASE2 Based on data supporting the use of cyclophosphamide and etoposide both as ...
Show More Location
Central Jersey Oncology Center
Learn More & Join Trial